The FDA has approved dupilumab to treat allergic fungal rhinosinusitis in adults and children ages 6 years and older.
Montreal Gazette on MSNOpinion

Labos: Nasal strips don't pass the sniff test

The internet is full of health and wellness products that are cheap, seem harmless and are vague enough in their marketing ...
Try Patanjali Shila Tulsi Drop (30 Ml) to get immunity, relief from cough and cold, improve respiratory health, and boost ...
US FDA approves Sanofi and Regeneron’s Dupixent for allergic fungal rhinosinusitis: Paris Thursday, February 26, 2026, 15:00 Hrs [IST] The US Food and Drug Administration (FDA) ...
Here's what a neti pot is, when to use one and how to do so safely.
You know that feeling, right? A stuffy nose hits you out of nowhere. Your throat feels scratchy. Your muscles ache. I' ...
People with allergic fungal rhinosinusitis taking Dupixent saw significant improvement in congestion and sinus inflammation, ...
“I didn't think I would use this for beauty regimen and health benefits, but it is heaven.” ...
Research on water intake more broadly suggests drinking more fluids can help with weight control by increasing feelings of ...
Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...
The FDA granted approval to dupilumab for treating patients aged 6 years and up with allergic fungal rhinosinusitis and a history of sino-nasal surgery, marking the first treatment approved for this ...